ABSTRACT
To address the COVID-19 situation in Indonesia, the Indonesian government has adopted a number of policies. One of them is a vacation-related policy. Government measures with regard to this vacation policy have produced a wide range of viewpoints in society, which have been extensively shared on social media, including YouTube. However, there has not been any computerized system developed to date that can assess people's social media reactions. Therefore, this paper provides a sentiment analysis application to this government policy by employing a bidirectional encoder representation from transformers (BERT) approach. The study method began with data collecting, data labeling, data preprocessing, BERT model training, and model evaluation. This study created a new dataset for this topic. The data were collected from the comments section of YouTube, and were categorized into three categories: positive, neutral, and negative. This research yielded an F-score of 84.33%. Another contribution from this study regards the methodology for processing sentiment analysis in Indonesian. In addition, the model was created as an application using the Python programming language and the Flask framework. The government can learn the extent to which the public accepts the policies that have been implemented by utilizing this research. © 2023 by the authors.
ABSTRACT
Background. Multiple countries affected by the Coronavirus disease 2019 (COVID-19) pandemic have noticed a drop in the number of patients attending the emergency department with acute stroke. This study aimed to assess the numbers of acute stroke admission during the COVID-19 pandemic in a major hospital in Yogyakarta. Methods. This is a retrospective study design of stroke admissions, data on the numbers of hospital admissions and mortality from the same period (March to December) in 2019 and 2020 were collected. The data were analyzed descriptively. Results. We collected data from a total of 1928 patients admitted with acute stroke. From March to December, the mean rate of admission was 114.9 cases per month in 2019 (Pre-COVID era), which dropped to 77.9 cases per month in 2020 (COVID era), with an overall reduction of 32.2%. There was a decrease in the numbers of ischemic (-36%) and hemorrhagic (-18%) stroke admissions during the state of the COVID-19 era compared with 2019. Furthermore, we also observed a reduction in the mortality rate of ischemic (-43%) and hemorrhagic (-1%) stroke patients. Conclusions. The COVID-19 pandemic had an impact on the care for stroke patients, resulting fell in acute stroke admissions and mortality rate.
ABSTRACT
Previous evidence has linked the relationship between newly onset skin disorder and SARS-CoV-2 infection. Cutaneous manifestations have been reported after exposure to COVID-19 vaccines that are linked to body immune responses. There is limited information about skin disorder that occurs after the COVID-19 vaccination. We report a case of varicella-zoster virus reactivation following inactivated COVID-19 vaccination in a young female patient.
ABSTRACT
Coronavirus disease 2019 (COVID-19) mainly invades the respiratory system, yet previous reports have shown unusual manifestations of COVID-19, including cerebrovascular events. However, detailed case reports are still lacking. A 57-year-old male presented with sudden unconsciousness and right side lateralization for 6 hours before hospital admission. His test results were positive for severe acute respiratory syndrome coronavirus 2 infection. The head computed tomography (CT) scan showed infarction within the middle cerebral artery region. The scan was repeated 48 hours after admission and showed a massive infarct in the left hemisphere with hemorrhagic transformation. A chest CT showed the appearance of bronchopneumonia with ground-glass opacities in both lungs. The patient's condition was rapidly deteriorating, and he died on the third day after admission. Our findings suggest that ischemic vascular events may simultaneously develop due to the progression of COVID-19. A hypercoagulable state and vascular endothelial dysfunction have been proposed as complications of COVID-19 and are risk factors of thrombotic vascular events.
ABSTRACT
Coronavirus disease 2019 (COVID-19) mainly invades the respiratory system, yet previous reports have shown unusual manifestations of COVID-19, including cerebrovascular events. However, detailed case reports are still lacking. A 57-year-old male presented with sudden unconsciousness and right side lateralization for 6 hours before hospital admission. His test results were positive for severe acute respiratory syndrome coronavirus 2 infection. The head computed tomography (CT) scan showed infarction within the middle cerebral artery region. The scan was repeated 48 hours after admission and showed a massive infarct in the left hemisphere with hemorrhagic transformation. A chest CT showed the appearance of bronchopneumonia with ground-glass opacities in both lungs. The patient's condition was rapidly deteriorating, and he died on the third day after admission. Our findings suggest that ischemic vascular events may simultaneously develop due to the progression of COVID-19. A hypercoagulable state and vascular endothelial dysfunction have been proposed as complications of COVID-19 and are risk factors of thrombotic vascular events.
ABSTRACT
COVID-19 preventions have cut access to routine medical care, especially for many chronic neurological disease patients. This condition has especially promoted telemedicine use in providing healthcare. This study aims to review telemedicine use catalyzed by several regulations of the Indonesian Government and review 20 cases from Bethesda Hospital in Yogyakarta providing online consultation services. Perceptions of experience on telemedicine were collected from neurological patients at the hospital who were asked about their impressions of consultations and pharmacy medication services, and their suggestions about the new system in outpatient consultations. The regulations for telemedicine use are relevant because of these patients' risks related to comorbidities and treatments. Of 20 respondents involved in this study, 15 (75%) were satisfied with the service, 3 (15%) very satisfied, and 2 (10%) others neutral. Most respondents suggest improvement of reimbursement (80%) and others suggest improvement on medications (10%) and services (10%). System and hospital requirements for telemedicine services for neurological cases have been accelerated due to the pandemic. Telemedicine is a way to provide healthcare needed by patients at high risks for COVID-19 fatality related to comorbidities and treatments. Payment regulations, regulatory structures, state licensing, and credentialing across hospitals for better telemedicine experience need to be enhanced.
ABSTRACT
Background and Aim: Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease that has affected every aspect of life in many countries. Previous studies suggested that the role of vitamin D in the immune system has certain significances in managing COVID-19 patients. This study aims to report the level of vitamin D in COVID-19 patients. Methods: We collected a series of confirmed cases from period of March through May 2020. The data collected including clinical symptoms, clinical signs, and laboratory examinations from 10 COVID-19 patients in Bethesda Hospital, Yogyakarta, Indonesia. This study used ELFA (enzyme-linked fluorescent assay) to measure vitamin D levels in serum or plasma. The collected data was analysed descriptively. Results: This study examined 10 patients with mean age of 49.6, ranging from 14 to 73 years old and most common age group was <60 years (60%). The gender ratio was equal between men and women (50:50). Most common symptoms were fatigue (60%) and fever (50%), whereas hypertension (40%) was the most common comorbidity. Most of patients (90%) had vitamin D deficiency (<20 ng/mL) and only 1 patient (10%) had insufficient vitamin D levels (<30 ng/mL). Conclusion: All of the COVID-19 patients in this study had suffered a decreased vitamin D levels, and more common in non-elderly patients. This is a novel findings of vitamin D deficiency in COVID-19 and has not been reported yet. Physicians should be aware in managing COVID-19 patients, especially the risk of vitamin D deficiency.